254 related articles for article (PubMed ID: 36139419)
1. Macrophages Upregulate Estrogen Receptor Expression in the Model of Obesity-Associated Breast Carcinoma.
Nahmias Blank D; Hermano E; Sonnenblick A; Maimon O; Rubinstein AM; Drai E; Maly B; Vlodavsky I; Popovtzer A; Peretz T; Meirovitz A; Elkin M
Cells; 2022 Sep; 11(18):. PubMed ID: 36139419
[TBL] [Abstract][Full Text] [Related]
2. Obesity associated alterations in the biology of adipose stem cells mediate enhanced tumorigenesis by estrogen dependent pathways.
Strong AL; Strong TA; Rhodes LV; Semon JA; Zhang X; Shi Z; Zhang S; Gimble JM; Burow ME; Bunnell BA
Breast Cancer Res; 2013; 15(5):R102. PubMed ID: 24176089
[TBL] [Abstract][Full Text] [Related]
3. Obesity-Altered Adipose Stem Cells Promote ER⁺ Breast Cancer Metastasis through Estrogen Independent Pathways.
Sabol RA; Beighley A; Giacomelli P; Wise RM; Harrison MAA; O'Donnnell BA; Sullivan BN; Lampenfeld JD; Matossian MD; Bratton MR; Wang G; Collins-Burow BM; Burow ME; Bunnell BA
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30897853
[TBL] [Abstract][Full Text] [Related]
4. Heparanase Accelerates Obesity-Associated Breast Cancer Progression.
Hermano E; Goldberg R; Rubinstein AM; Sonnenblick A; Maly B; Nahmias D; Li JP; Bakker MAH; van der Vlag J; Vlodavsky I; Peretz T; Elkin M
Cancer Res; 2019 Oct; 79(20):5342-5354. PubMed ID: 31481501
[TBL] [Abstract][Full Text] [Related]
5. FGFR1 underlies obesity-associated progression of estrogen receptor-positive breast cancer after estrogen deprivation.
Wellberg EA; Kabos P; Gillen AE; Jacobsen BM; Brechbuhl HM; Johnson SJ; Rudolph MC; Edgerton SM; Thor AD; Anderson SM; Elias A; Zhou XK; Iyengar NM; Morrow M; Falcone DJ; El-Hely O; Dannenberg AJ; Sartorius CA; MacLean PS
JCI Insight; 2018 Jul; 3(14):. PubMed ID: 30046001
[TBL] [Abstract][Full Text] [Related]
6. Excess body weight and postmenopausal breast cancer: Emerging molecular mechanisms and perspectives.
Nahmias-Blank D; Maimon O; Meirovitz A; Sheva K; Peretz-Yablonski T; Elkin M
Semin Cancer Biol; 2023 Nov; 96():26-35. PubMed ID: 37739109
[TBL] [Abstract][Full Text] [Related]
7. Cholesterol biosynthesis pathway as a novel mechanism of resistance to estrogen deprivation in estrogen receptor-positive breast cancer.
Simigdala N; Gao Q; Pancholi S; Roberg-Larsen H; Zvelebil M; Ribas R; Folkerd E; Thompson A; Bhamra A; Dowsett M; Martin LA
Breast Cancer Res; 2016 Jun; 18(1):58. PubMed ID: 27246191
[TBL] [Abstract][Full Text] [Related]
8. Estrogens and breast cancer: Mechanisms involved in obesity-related development, growth and progression.
Bhardwaj P; Au CC; Benito-Martin A; Ladumor H; Oshchepkova S; Moges R; Brown KA
J Steroid Biochem Mol Biol; 2019 May; 189():161-170. PubMed ID: 30851382
[TBL] [Abstract][Full Text] [Related]
9. FGF1 supports glycolytic metabolism through the estrogen receptor in endocrine-resistant and obesity-associated breast cancer.
Castillo-Castrejon M; Sankofi BM; Murguia SJ; Udeme AA; Cen HH; Xia YH; Thomas NS; Berry WL; Jones KL; Richard VR; Zahedi RP; Borchers CH; Johnson JD; Wellberg EA
Breast Cancer Res; 2023 Aug; 25(1):99. PubMed ID: 37608351
[TBL] [Abstract][Full Text] [Related]
10. Obesity, estrogen production, and tumor estrogen receptors in women with carcinoma of the breast.
Donegan WL; Johnstone MF; Biedrzycki L
Am J Clin Oncol; 1983 Feb; 6(1):19-24. PubMed ID: 6837504
[TBL] [Abstract][Full Text] [Related]
11. Estrogen-induced SDF-1α production promotes the progression of ER-negative breast cancer via the accumulation of MDSCs in the tumor microenvironment.
Ouyang L; Chang W; Fang B; Qin J; Qu X; Cheng F
Sci Rep; 2016 Dec; 6():39541. PubMed ID: 27996037
[TBL] [Abstract][Full Text] [Related]
12. Progesterone receptor status modifies the association between body mass index and prognosis in women diagnosed with estrogen receptor positive breast cancer.
Oudanonh T; Nabi H; Ennour-Idrissi K; Lemieux J; Diorio C
Int J Cancer; 2020 May; 146(10):2736-2745. PubMed ID: 31403177
[TBL] [Abstract][Full Text] [Related]
13. Obesity-Altered Adipose Stem Cells Promote Radiation Resistance of Estrogen Receptor Positive Breast Cancer through Paracrine Signaling.
Sabol RA; Villela VA; Denys A; Freeman BT; Hartono AB; Wise RM; Harrison MAA; Sandler MB; Hossain F; Miele L; Bunnell BA
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326381
[TBL] [Abstract][Full Text] [Related]
14. Leptin-induced ER-α-positive breast cancer cell viability and migration is mediated by suppressing CCN5-signaling via activating JAK/AKT/STAT-pathway.
Haque I; Ghosh A; Acup S; Banerjee S; Dhar K; Ray A; Sarkar S; Kambhampati S; Banerjee SK
BMC Cancer; 2018 Jan; 18(1):99. PubMed ID: 29370782
[TBL] [Abstract][Full Text] [Related]
15. Preclinical and clinical studies of estrogen deprivation support the PDGF/Abl pathway as a novel therapeutic target for overcoming endocrine resistance in breast cancer.
Weigel MT; Ghazoui Z; Dunbier A; Pancholi S; Dowsett M; Martin LA
Breast Cancer Res; 2012 May; 14(3):R78. PubMed ID: 22608253
[TBL] [Abstract][Full Text] [Related]
16. The effect of adipocyte-macrophage crosstalk in obesity-related breast cancer.
Engin AB; Engin A; Gonul II
J Mol Endocrinol; 2019 Apr; 62(3):R201-R222. PubMed ID: 30620711
[TBL] [Abstract][Full Text] [Related]
17. Estrogen promotes stemness and invasiveness of ER-positive breast cancer cells through Gli1 activation.
Sun Y; Wang Y; Fan C; Gao P; Wang X; Wei G; Wei J
Mol Cancer; 2014 Jun; 13():137. PubMed ID: 24889938
[TBL] [Abstract][Full Text] [Related]
18. Mammary adipose stromal cells derived from obese women reduce sensitivity to the aromatase inhibitor anastrazole in an organotypic breast model.
Morgan MM; Arendt LM; Alarid ET; Beebe DJ; Johnson BP
FASEB J; 2019 Jul; 33(7):8623-8633. PubMed ID: 31002529
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological Characteristics and Breast Cancer-Specific Survival of Patients With Single Hormone Receptor-Positive Breast Cancer.
Li Y; Yang D; Yin X; Zhang X; Huang J; Wu Y; Wang M; Yi Z; Li H; Li H; Ren G
JAMA Netw Open; 2020 Jan; 3(1):e1918160. PubMed ID: 31899528
[TBL] [Abstract][Full Text] [Related]
20. Endometrial polyps in obese asymptomatic pre and postmenopausal patients with breast cancer: is screening necessary?
Lubián López DM; Orihuela López F; García-Berbel Molina L; Boza Novo P; Pozuelo Solís E; Menor Almagro D; Comino Delgado R
Gynecol Oncol; 2014 Apr; 133(1):56-62. PubMed ID: 24680592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]